ACUMEN PHARMACEUTICALS INC shareholders Q3 2023

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

ACUMEN PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
Ikarian Capital, LLC 315,265$1,308,3500.16%
CATALYST FINANCIAL PARTNERS LLC 89,699$372,2510.12%
Intrepid Financial Planning Group LLC 30,150$125,1230.06%
Laurion Capital Management LP 1,895,023$7,864,3450.05%
Schonfeld Strategic Advisors LLC 645,112$2,677,2140.02%
Hudson Bay Capital Management LP 1,050,000$4,357,5000.02%
Alyeska Investment Group, L.P. 613,822$2,547,3610.02%
PATHSTONE FAMILY OFFICE, LLC 478,790$1,986,9790.02%
XTX Topco Ltd 16,538$68,6330.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,033$477,3870.01%
External links

This page lists ACUMEN PHARMACEUTICALS INC's shareholders in Q3 2023. To view ACUMEN PHARMACEUTICALS INC's shareholder history, click here.